Cardiovascular and renal outcome trials reporting outcomes on GLP-1RA, SGLT-2 inhibitors and DPP-4 inhibitors in patients with or without type 2 diabetes mellitus were included
Tell the provider about all prescriptions, supplements, allergies and medical conditions
Body Composition & Metabolic Health Sexual Enhancement We offer personalized supplement plans with the goal of supporting various aspects of health, including metabolism and overall well-being
Consequently, although obesity affects hundreds of millions of people globally, GLP-1 therapies currently reach only a small fraction of eligible patients, underscoring the substantial unmet need for more convenient, scalable, and accessible treatment options
In individuals with irritable bowel syndrome, chrons disease, and ulcerative colitis, intravenous and intramuscular routes may be preferred